Compare MACOM Technology (MTSI) vs Nuvation Bio Inc. Class A Common Stock (NUVB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MACOM Technology vs Nuvation Bio Inc. Class A Common Stock — how do they compare? MACOM Technology trades at $327 (market cap $24.61B), while Nuvation Bio Inc. Class A Common Stock trades at $4.93 (market cap $1.74B). The key difference: MACOM Technology is far larger — about 14.1× Nuvation Bio Inc. Class A Common Stock's market cap, and MACOM Technology is trading nearer its 52-week high, Nuvation Bio Inc. Class A Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MACOM Technology for 6 Days and Nuvation Bio Inc. Class A Common Stock for 0 Days on average.
| MTSI | NUVB | |
|---|---|---|
Market Cap | $24.61B | $1.74B |
Volume | 1,594,575 | 9,289,619 |
Sector | Technology | Health |
52-Week High | $409.68 | $9.54 |
52-Week Low | $122.18 | $3.41 |
Typical Hold Time | 6 Days | 0 Days |
Enterprise Value | $24.32B | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About MACOM Technology
MACOM develops analog, radio frequency, microwave, and optical semiconductors. Its components are used in telecommunications, data centers, industrial systems, aerospace, and defense applications.
Read more on MTSI →About Nuvation Bio Inc. Class A Common Stock
Nuvation Bio Inc. is a biopharmaceutical company focused on oncology, developing novel cancer treatments including taletrectinib (marketed as IBTROZI), a ROS1 inhibitor, and safusidenib, a brain-penetrant IDH1 inhibitor.
Read more on NUVB →
